New Targets to Enhance the Effectiveness of PARP Inhibitors in Cancer Research

Jun 14, 2024 | News

The ultimate goal of cancer therapy is to eliminate malignant cells with minimal side effects. Modern approaches increasingly focus on targeting specific molecular pathways critical for tumor survival and proliferation, rather than relying on traditional cytotoxic agents that kill cells indiscriminately.

Three HUN-REN BRC Szeged researchers won the János Bolyai Research Scholarship

Jun 13, 2024 | News

On 12 June 2024, the Hungarian Academy of Sciences (HAS) published the list of this year's winners of the János Bolyai Research Scholarship. The Bolyai Scholarship was established in 1997 "to encourage and recognise outstanding research and development achievements". Researchers under 45 years of age could apply for the 250.000Ft monthly grant for a period of 1, 2 or 3 years.

A journey to your (immune) self

May 14, 2024 | News

Essentially, the immune system's primary function is to differentiate between our own harmless molecules and potentially harmful foreign ones. This distinction is largely influenced by the degree of similarity a molecule bears to those the immune system is exposed to early in life.

Straub-Days 2024

May 10, 2024 | News

On May 30 and 31, 2024, the "Straub-Days" of the HUN-REN Biological Research Centre, Szeged (HUN-REN BRC Szeged) will take place in the institute building in Temesvári körút. The event is organized by the HUN-REN BRC Szeged and the Hungarian Centre of Excellence of Molecular Medicine (HCEMM). The organizers welcome all interested parties.

Bálint Kintses Receives Szent-Györgyi Talent Award for Antibiotic Resistance Research

Apr 22, 2024 | News

This year, Bálint Kintses, leader of the Translational Microbiology Laboratory at the BRC was honored for his innovative work on antibiotic resistance, published in Nature Microbiology.


 

New discovery sheds light on the survival strategy of Antarctic bacteria

Feb 23, 2024 | News

The overwhelming majority of our biological knowledge stems from the study of organisms found in our immediate surroundings or from within our own bodies. This holds true for bacteria as well, as the most well-studied species are from environments inhabited by humans or from within the human body itself. However, there are numerous conditions where the majority of these species are unable to survive but other bacteria are able to survive and even thrive. One such example are species belonging to the genus Psychrobacter, which can be found living in the icy terrain of Antarctica.

BRC Researchers participate in a Horizon Europe consortium unraveling the interplay between infectious diseases and noncommunicable diseases

Jan 22, 2024 | News

The Systems Immunology Research Group at HUN-REN Biological Research Centre, Szeged led by Máté Manczinger is participating in a HORIZON-HEALTH-2023-DISEASE-03 project named ID-DarkMatter-NCD.

As part of the Algae4IBD research project, Bettina Ughy and her colleagues are investigating the applicability of algae in the treatment of IBD

Jan 18, 2024 | News

The Algae4IBD project (https://algae4ibd.eu/) brings together 21 researcher institutes and companies from 11 countries to unify their expertise in different fields to help patients with chronic inflammatory bowel disease (IBD). Chronic inflammation of the digestive tract is a very complex disease for which there is no universally applicable treatment. Since algae are known to produce specific bioactive molecules, they are a promising source when looking for new therapeutic agents.

Viktória Lázár at the HUN-REN BRC Szeged received the EMBO Installation Grant 50.000 euros per year

Jan 16, 2024 | News

Ten life scientists from seven countries (Czech Republic, Greece, Hungary, Lithuania, Poland, Portugal and Turkey) have been awarded EMBO Installation Grants, that support group leaders who will move or have recently moved to countries participating in the scheme. In the four years prior to their application, they have spent at least two consecutive years outside the country where they are now setting up their laboratory. The ten funded applications span a broad range of biological processes including aging, tumor biology, gut-brain axis communication, microbiota, and gene editing tools.

Katalin Karikó has been awarded the 2023 Nobel Prize in Physiology or Medicine

Oct 2, 2023 | News

The Nobel Assembly at the Karolinska Institutet announced that Katalin Karikó and Drew Weissman have been awarded the 2023 Nobel Prize in Physiology or Medicine for "for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19"